Not too long ago, pharmaceutical giant Astrazeneca reached a £200bn valuation—one of only a few London-listed FTSE 100 ...
The company believes Chinese authorities are probing allegations that two current and two former employees had illegally ...
AstraZeneca is scheduled to report results for the third quarter on Tuesday. Here is what to know. CORE EARNINGS PER SHARE: One of the Anglo-Swedish pharmaceutical major's preferred metrics, core EPS ...
AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an ...
AstraZeneca said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not ...
Investopedia on MSN5d
AstraZeneca Shares Slide As Execs in China Face Fraud InvestigationAstraZeneca shares declined Tuesday after reports that senior executives in China were potentially implicated in an insurance ...
AstraZeneca Plc shares plunged in London, erasing about £14 billion ($18 billion) of market value, amid escalating concerns ...
Two current and two former senior AstraZeneca Plc executives in the group’s China unit are under investigation in a probe ...
Hosted on MSN1d
Is AstraZeneca PLC (AZN) The Best UK Stock to Invest in Now?We recently compiled a list of the 10 Best UK Stocks to Invest in Now. In this article, we are going to take a look at where ...
China's investigation of AstraZeneca's top executive in the country is raising questions about the company's tactics there.
Fierce Pharma Asia—AstraZeneca's China fallout; Pfizer's $1B plan in China; Incyte-Sun JAK dispute
AstraZeneca's China president has been detained by Chinese authorities amid investigation into illegal importation and ...
2don MSN
AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback